NeuralBase AI Ltd. Advances HeartEase App Development with Android Version Ready for Testing

NeuralBase AI Ltd. has announced the completion of the Android version of its HeartEase app, now entering the final testing phase, with the iOS version to follow shortly. This development is a critical milestone in the company's effort to provide AI-driven insights into cardiovascular and emotional health, leveraging proprietary technology for intelligent monitoring and personalized wellness recommendations.

The HeartEase app is designed to transform proactive wellness management by offering real-time feedback and tailored advice. The completion of the Android version not only signifies progress towards the app's public release but also enables the validation of the platform's technology in real-world scenarios. Vighnesh Dobale, CEO of NeuralBase AI Ltd., emphasized the importance of this step in achieving feature parity and consistent performance across both Android and iOS platforms.

Anticipated to gather valuable user feedback upon launch, HeartEase is expected to undergo further refinements, potentially leading to collaborations with healthcare providers and wearable technology companies. This initiative is part of NeuralBase AI Ltd.'s broader strategy to expand its AI-powered digital health ecosystem, focusing on preventive health diagnostics and enterprise wellness solutions to meet the increasing demand for innovative health monitoring tools.

For additional information on NeuralBase AI Ltd., interested parties can visit https://www.neuralbase.ai or consult the Securities & Exchange Commission's EDGAR database at https://www.sec.gov.